Seroepidemiological Study of SARS-CoV-2 (COVID-19) Infection in Population Subgroups in the State of São Paulo

Butantan Institute18,901 enrolled

Overview

Seroepidemiological Study of SARS-CoV-2 Infection in Population Subgroups in the State of São Paulo

This is a cross-sectional study to estimate the prevalence of antibodies against SARS-CoV-2 is different population subgroups in the State of São Paulo

Study Type

OBSERVATIONAL

Enrollment

18,901

Conditions

COVID SARS-CoV 2

Interventions

Serological testDIAGNOSTIC_TEST

IgM and IgG for SARS-CoV-2

Nasopharyngeal SwabDIAGNOSTIC_TEST

PCR for SARS-CoV-2

Oropharyngeal SwabDIAGNOSTIC_TEST

PCR for SARS-CoV-2

Eligibility

Sex: ALLMin age: 6 MonthsMax age: 100 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * All potential volunteers invited to participate in the study. Exclusion Criteria: * All potential eligible participants, but who do not show interest in participating in the study.

Locations (1)

Avenida Vital Brasil 1500

São Paulo, Brazil

Outcomes

Primary Outcomes

Prevalence of antibodies against SARS-CoV-2 through serological testing

IgM and IgG antibodies against SARS-CoV-2

Time frame: 1 month

Frequency of participants with a positive RT-PCR test result for SARS-CoV-2

Positive RT-PCR test result for SARS-CoV-2

Time frame: 1 month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.